NEUROTECH INTERNATIONAL LIMITED - Announcements

Market Cap $78.33M Add to my watchlist

Healthcare Medical Devices

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Combining science, nature and human compassion, Little Green Pharma (ASX:LGP) are committed to improving the quality of life for sufferers of debilitating chronic conditions. NEWS: Little Green Pharma shares surge as Germany legalises Cannabis.

Announcements

Filter Results

All Price Sensitive Only

NTI	Response to ASX Price Query	PRICE SENSITIVE	24/04/19	414.61KB	Share
NTI	Details of Company Address		23/04/19	55.87KB	Share
NTI	Initial Director's Interest Notice		18/04/19	150.95KB	Share
NTI	Initial Director's Interest Notice		18/04/19	150.42KB	Share
NTI	Appendix 3Z - P O'Connor		17/04/19	177.1KB	Share
NTI	Appendix 3Z - N Fong		17/04/19	176.71KB	Share
NTI	Appendix 3Z - S Trevisan		17/04/19	179.3KB	Share
NTI	New Board Appointments		16/04/19	174.6KB	Share
NTI	Ceasing to be a substantial holder		08/04/19	148.91KB	Share
NTI	Dr Adrian Attard Trevisan, clarification		28/03/19	117.51KB	Share
NTI	Dr Adrian Attard Trevisan	PRICE SENSITIVE	27/03/19	122.01KB	Share
NTI	New Subscription Model and E-Commerce platform for clinics		18/03/19	155.73KB	Share
NTI	Maltese Former Employee Claim		07/03/19	152.36KB	Share
NTI	Appendix 3Y - P O'Connor		01/03/19	212.8KB	Share
NTI	Appendix 3Y - P Griffiths		01/03/19	232.28KB	Share
NTI	Appendix 3Y - S Trevisan		01/03/19	214.1KB	Share
NTI	Appendix 4D and 31 December 2018 Half Year Report	PRICE SENSITIVE	28/02/19	1.01MB	Share
NTI	Becoming a substantial holder		28/02/19	621.41KB	Share
NTI	Change in substantial holding		27/02/19	188.88KB	Share
NTI	Appendix 3B		25/02/19	469.88KB	Share
NTI	RENOUNCEABLE PRO-RATA RIGHTS ISSUE	PRICE SENSITIVE	25/02/19	126.97KB	Share
NTI	Neurotech secures digital marketing partner		15/02/19	158.54KB	Share
NTI	Supplementary Prospectus	PRICE SENSITIVE	07/02/19	126.71KB	Share
NTI	Despatch of Prospectus		06/02/19	171.94KB	Share
NTI	Despatch of Notices to Shareholders		31/01/19	385.33KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/01/19	498.23KB	Share
NTI	Despatch of Notice to Optionholders		30/01/19	323.77KB	Share
NTI	Appendix 3B		30/01/19	521.71KB	Share
NTI	CEO and Managing Director remuneration		29/01/19	161.77KB	Share
NTI	Appendix 3B		29/01/19	490.22KB	Share
NTI	Prospectus - Renounceable Rights Issue	PRICE SENSITIVE	29/01/19	398.28KB	Share
NTI	Investor Presentation - Amended		29/01/19	1.26MB	Share
NTI	Investor Presentation	PRICE SENSITIVE	29/01/19	1.06MB	Share
NTI	Neurotech Rights Issue	PRICE SENSITIVE	29/01/19	227.03KB	Share
NTI	New Direction for US Market		21/12/18	182.78KB	Share
NTI	Return of Founder as Strategic Advisor		20/12/18	169.82KB	Share
NTI	Appendix 3Y - D Cantor		04/12/18	216.43KB	Share
NTI	Appendix 3B		04/12/18	427.62KB	Share
NTI	Clarification - Results of Annual General Meeting		30/11/18	138.69KB	Share
NTI	Appendix 3Z - C Tan		30/11/18	184.42KB	Share
NTI	Results of Annual General Meeting		30/11/18	135.79KB	Share
NTI	Chairman's Address, 2018 Annual General Meeting		30/11/18	229.81KB	Share
NTI	Appendix 3Z - W Storf		26/11/18	189.73KB	Share
NTI	Appointment of Peter Griffiths as CEO	PRICE SENSITIVE	26/11/18	158.62KB	Share
NTI	Appenxidx 3B		16/11/18	350.19KB	Share
NTI	Mente presentation at International Congress on Autism		13/11/18	201.37KB	Share
NTI	Change in substantial holding		12/11/18	703.46KB	Share
NTI	AGM Notice of Meeting - Despatch		31/10/18	531.48KB	Share
NTI	New Appointments	PRICE SENSITIVE	23/10/18	189.26KB	Share
NTI	Quarterly report	PRICE SENSITIVE	19/10/18	2.87MB	Share
NTI	Change of Address		08/10/18	172.41KB	Share
NTI	Initial Director's Interest Notice		04/10/18	206.29KB	Share
NTI	Shipment of Mente Autism devices	PRICE SENSITIVE	04/10/18	219.17KB	Share
NTI	Appointment of Dr Neale Fong to the Board		03/10/18	166.36KB	Share
NTI	Mente Autism - FDA Clearance Application	PRICE SENSITIVE	02/10/18	169.98KB	Share
NTI	Appendix 4E and Annual Report	PRICE SENSITIVE	03/09/18	945.04KB	Share
NTI	Appendix 4G		31/08/18	287.67KB	Share
NTI	Corporate Governance Statement		31/08/18	427.82KB	Share
NTI	Change in substantial holding		20/08/18	220.42KB	Share
NTI	Investor Presentation		13/08/18	1.99MB	Share
NTI	First Shipments of Mente Autism	PRICE SENSITIVE	10/08/18	186.77KB	Share
NTI	Quarterly report and Appendix 4C	PRICE SENSITIVE	31/07/18	427.62KB	Share
NTI	US Clinical Trial / Investor Webinar		12/07/18	3.06MB	Share
NTI	Webinar Presentation		12/07/18	2.78MB	Share
NTI	Investor Webinar		10/07/18	169.43KB	Share
NTI	US Clinical Trial Results Published	PRICE SENSITIVE	09/07/18	1.73MB	Share
NTI	Initial Director's Interest Notice		06/07/18	174.43KB	Share
NTI	Trading Halt	PRICE SENSITIVE	05/07/18	352.7KB	Share
NTI	Neuroscience expert Dr David Cantor appointed to the board		04/07/18	169.94KB	Share
NTI	Final Director's Interest Notice		28/06/18	185.93KB	Share
NTI	Board Change		28/06/18	161.94KB	Share
NTI	Change in substantial holding		27/06/18	145.62KB	Share
NTI	Clinical Trial Publication Provisionally Accepted		25/06/18	333.85KB	Share
NTI	Mente Autism Approval From Italcert	PRICE SENSITIVE	04/06/18	169.99KB	Share
NTI	Appendix 3B		14/05/18	249.25KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/04/18	370.77KB	Share
NTI	Appendix 4D and 31 December 2017 Half Year Financial Report	PRICE SENSITIVE	28/02/18	439.78KB	Share
NTI	Amendment to December 2017 Quarterly Report		05/02/18	777.66KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/01/18	783.6KB	Share
NTI	Change in substantial holding		22/01/18	129.76KB	Share
NTI	Indian Distribution Agreement	PRICE SENSITIVE	18/01/18	582.09KB	Share
NTI	Clarification Statement		10/01/18	572.86KB	Share
NTI	Becoming a substantial holder		10/01/18	146.57KB	Share
NTI	Clinical Trial Update		08/01/18	593.49KB	Share
NTI	Change of Directors Interest Notice		30/11/17	364.02KB	Share
NTI	Change of Directors Interest Notice		30/11/17	363.65KB	Share
NTI	Appendix 3B		30/11/17	704.07KB	Share
NTI	Design Agreement with eemagine	PRICE SENSITIVE	27/11/17	578.27KB	Share
NTI	2017 AGM Results		23/11/17	374.75KB	Share
NTI	AGM Presentation		23/11/17	1.95MB	Share
NTI	Investor Call		09/11/17	583.01KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/10/17	906.16KB	Share
NTI	Announcement Correction		25/10/17	476.75KB	Share
NTI	Appendix 3B		25/10/17	688.97KB	Share
NTI	Allotment of Placement Shares		25/10/17	483.42KB	Share
NTI	Notice of Meeting - Despatch		23/10/17	1.56MB	Share
NTI	Reinstatement to Official Quotation	PRICE SENSITIVE	16/10/17	251.67KB	Share
NTI	Capital Raising Completed	PRICE SENSITIVE	16/10/17	595.56KB	Share
NTI	Suspension from Official Quotation	PRICE SENSITIVE	12/10/17	559.91KB	Share
NTI	Trading Halt	PRICE SENSITIVE	11/10/17	764.02KB	Share

NTI Response to ASX Price Query
24/04/19	PRICE SENSITIVE	414.61KB	Share
NTI Details of Company Address
23/04/19		55.87KB	Share
NTI Initial Director's Interest Notice
18/04/19		150.95KB	Share
NTI Initial Director's Interest Notice
18/04/19		150.42KB	Share
NTI Appendix 3Z - P O'Connor
17/04/19		177.1KB	Share
NTI Appendix 3Z - N Fong
17/04/19		176.71KB	Share
NTI Appendix 3Z - S Trevisan
17/04/19		179.3KB	Share
NTI New Board Appointments
16/04/19		174.6KB	Share
NTI Ceasing to be a substantial holder
08/04/19		148.91KB	Share
NTI Dr Adrian Attard Trevisan, clarification
28/03/19		117.51KB	Share
NTI Dr Adrian Attard Trevisan
27/03/19	PRICE SENSITIVE	122.01KB	Share
NTI New Subscription Model and E-Commerce platform for clinics
18/03/19		155.73KB	Share
NTI Maltese Former Employee Claim
07/03/19		152.36KB	Share
NTI Appendix 3Y - P O'Connor
01/03/19		212.8KB	Share
NTI Appendix 3Y - P Griffiths
01/03/19		232.28KB	Share
NTI Appendix 3Y - S Trevisan
01/03/19		214.1KB	Share
NTI Appendix 4D and 31 December 2018 Half Year Report
28/02/19	PRICE SENSITIVE	1.01MB	Share
NTI Becoming a substantial holder
28/02/19		621.41KB	Share
NTI Change in substantial holding
27/02/19		188.88KB	Share
NTI Appendix 3B
25/02/19		469.88KB	Share
NTI RENOUNCEABLE PRO-RATA RIGHTS ISSUE
25/02/19	PRICE SENSITIVE	126.97KB	Share
NTI Neurotech secures digital marketing partner
15/02/19		158.54KB	Share
NTI Supplementary Prospectus
07/02/19	PRICE SENSITIVE	126.71KB	Share
NTI Despatch of Prospectus
06/02/19		171.94KB	Share
NTI Despatch of Notices to Shareholders
31/01/19		385.33KB	Share
NTI Quarterly Report and Appendix 4C
31/01/19	PRICE SENSITIVE	498.23KB	Share
NTI Despatch of Notice to Optionholders
30/01/19		323.77KB	Share
NTI Appendix 3B
30/01/19		521.71KB	Share
NTI CEO and Managing Director remuneration
29/01/19		161.77KB	Share
NTI Appendix 3B
29/01/19		490.22KB	Share
NTI Prospectus - Renounceable Rights Issue
29/01/19	PRICE SENSITIVE	398.28KB	Share
NTI Investor Presentation - Amended
29/01/19		1.26MB	Share
NTI Investor Presentation
29/01/19	PRICE SENSITIVE	1.06MB	Share
NTI Neurotech Rights Issue
29/01/19	PRICE SENSITIVE	227.03KB	Share
NTI New Direction for US Market
21/12/18		182.78KB	Share
NTI Return of Founder as Strategic Advisor
20/12/18		169.82KB	Share
NTI Appendix 3Y - D Cantor
04/12/18		216.43KB	Share
NTI Appendix 3B
04/12/18		427.62KB	Share
NTI Clarification - Results of Annual General Meeting
30/11/18		138.69KB	Share
NTI Appendix 3Z - C Tan
30/11/18		184.42KB	Share
NTI Results of Annual General Meeting
30/11/18		135.79KB	Share
NTI Chairman's Address, 2018 Annual General Meeting
30/11/18		229.81KB	Share
NTI Appendix 3Z - W Storf
26/11/18		189.73KB	Share
NTI Appointment of Peter Griffiths as CEO
26/11/18	PRICE SENSITIVE	158.62KB	Share
NTI Appenxidx 3B
16/11/18		350.19KB	Share
NTI Mente presentation at International Congress on Autism
13/11/18		201.37KB	Share
NTI Change in substantial holding
12/11/18		703.46KB	Share
NTI AGM Notice of Meeting - Despatch
31/10/18		531.48KB	Share
NTI New Appointments
23/10/18	PRICE SENSITIVE	189.26KB	Share
NTI Quarterly report
19/10/18	PRICE SENSITIVE	2.87MB	Share
NTI Change of Address
08/10/18		172.41KB	Share
NTI Initial Director's Interest Notice
04/10/18		206.29KB	Share
NTI Shipment of Mente Autism devices
04/10/18	PRICE SENSITIVE	219.17KB	Share
NTI Appointment of Dr Neale Fong to the Board
03/10/18		166.36KB	Share
NTI Mente Autism - FDA Clearance Application
02/10/18	PRICE SENSITIVE	169.98KB	Share
NTI Appendix 4E and Annual Report
03/09/18	PRICE SENSITIVE	945.04KB	Share
NTI Appendix 4G
31/08/18		287.67KB	Share
NTI Corporate Governance Statement
31/08/18		427.82KB	Share
NTI Change in substantial holding
20/08/18		220.42KB	Share
NTI Investor Presentation
13/08/18		1.99MB	Share
NTI First Shipments of Mente Autism
10/08/18	PRICE SENSITIVE	186.77KB	Share
NTI Quarterly report and Appendix 4C
31/07/18	PRICE SENSITIVE	427.62KB	Share
NTI US Clinical Trial / Investor Webinar
12/07/18		3.06MB	Share
NTI Webinar Presentation
12/07/18		2.78MB	Share
NTI Investor Webinar
10/07/18		169.43KB	Share
NTI US Clinical Trial Results Published
09/07/18	PRICE SENSITIVE	1.73MB	Share
NTI Initial Director's Interest Notice
06/07/18		174.43KB	Share
NTI Trading Halt
05/07/18	PRICE SENSITIVE	352.7KB	Share
NTI Neuroscience expert Dr David Cantor appointed to the board
04/07/18		169.94KB	Share
NTI Final Director's Interest Notice
28/06/18		185.93KB	Share
NTI Board Change
28/06/18		161.94KB	Share
NTI Change in substantial holding
27/06/18		145.62KB	Share
NTI Clinical Trial Publication Provisionally Accepted
25/06/18		333.85KB	Share
NTI Mente Autism Approval From Italcert
04/06/18	PRICE SENSITIVE	169.99KB	Share
NTI Appendix 3B
14/05/18		249.25KB	Share
NTI Quarterly Report and Appendix 4C
30/04/18	PRICE SENSITIVE	370.77KB	Share
NTI Appendix 4D and 31 December 2017 Half Year Financial Report
28/02/18	PRICE SENSITIVE	439.78KB	Share
NTI Amendment to December 2017 Quarterly Report
05/02/18		777.66KB	Share
NTI Quarterly Report and Appendix 4C
30/01/18	PRICE SENSITIVE	783.6KB	Share
NTI Change in substantial holding
22/01/18		129.76KB	Share
NTI Indian Distribution Agreement
18/01/18	PRICE SENSITIVE	582.09KB	Share
NTI Clarification Statement
10/01/18		572.86KB	Share
NTI Becoming a substantial holder
10/01/18		146.57KB	Share
NTI Clinical Trial Update
08/01/18		593.49KB	Share
NTI Change of Directors Interest Notice
30/11/17		364.02KB	Share
NTI Change of Directors Interest Notice
30/11/17		363.65KB	Share
NTI Appendix 3B
30/11/17		704.07KB	Share
NTI Design Agreement with eemagine
27/11/17	PRICE SENSITIVE	578.27KB	Share
NTI 2017 AGM Results
23/11/17		374.75KB	Share
NTI AGM Presentation
23/11/17		1.95MB	Share
NTI Investor Call
09/11/17		583.01KB	Share
NTI Quarterly Report and Appendix 4C
31/10/17	PRICE SENSITIVE	906.16KB	Share
NTI Announcement Correction
25/10/17		476.75KB	Share
NTI Appendix 3B
25/10/17		688.97KB	Share
NTI Allotment of Placement Shares
25/10/17		483.42KB	Share
NTI Notice of Meeting - Despatch
23/10/17		1.56MB	Share
NTI Reinstatement to Official Quotation
16/10/17	PRICE SENSITIVE	251.67KB	Share
NTI Capital Raising Completed
16/10/17	PRICE SENSITIVE	595.56KB	Share
NTI Suspension from Official Quotation
12/10/17	PRICE SENSITIVE	559.91KB	Share
NTI Trading Halt
11/10/17	PRICE SENSITIVE	764.02KB	Share

REFRESH

First 2 3 4 5

(20min delay)
Last 7.7¢		Change -0.001(1.28%)		Mkt cap ! $78.33M

Open	High	Low	Value	Volume
7.9¢	8.1¢	7.7¢	$54.26K	684.2K

Buyers (Bids)

No.	Vol.	Price($)
3	98220	7.7¢

Sellers (Offers)

Price($)	Vol.	No.
7.9¢	21369	1

View Market Depth

No.	Vol.	Price($)
3	98220	0.077
2	107894	0.076
3	263338	0.075
1	160000	0.074
3	149500	0.073

Price($)	Vol.	No.
0.079	21369	1
0.080	344270	2
0.081	40000	2
0.082	85000	1
0.086	100000	2

Last trade - 15.59pm 22/07/2024 (20 minute delay)


Last 7.7¢		Change -0.001 ( 2.53 %)
Open	High	Low	Volume
7.8¢	8.1¢	7.7¢	203193
Last updated 15.59pm 22/07/2024 ?

NTI (ASX) Chart

NEUROTECH INTERNATIONAL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories